Premium
Analytical characterization of “etonitazepyne,” a new pyrrolidinyl‐containing 2‐benzylbenzimidazole opioid sold online
Author(s) -
Blanckaert Peter,
Balcaen Margot,
Vanhee Céline,
Risseeuw Martijn,
Canfyn Michaël,
Desmedt Bart,
Van Calenbergh Serge,
Deconinck Eric
Publication year - 2021
Publication title -
drug testing and analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.065
H-Index - 54
eISSN - 1942-7611
pISSN - 1942-7603
DOI - 10.1002/dta.3113
Subject(s) - benzimidazole , chemistry , fourier transform infrared spectroscopy , chromatography , opioid , stereochemistry , combinatorial chemistry , organic chemistry , biochemistry , physics , quantum mechanics , receptor
This paper reports on the identification and full chemical characterization of the substance colloquially called “etonitazepyne” or “ N ‐pyrrolidino etonitazene” (2‐(4‐ethoxybenzyl)‐5‐nitro‐1‐(2‐(pyrrolidin‐1‐yl)ethyl)‐1 H ‐benzo[ d ]imidazole), a potent NPS opioid of the 5‐nitrobenzimidazole class. Identification of etonitazepyne was performed, on a sample purchased during routine monitoring of the drug market, using GC‐MS, HRAM LC‐MS/MS, 1 H NMR, and FTIR. The chromatographic data, together with the FTIR data, indicated the presence of a highly pure compound and already indicated a benzimidazole structure. The specific benzimidazole regio‐isomer was confirmed using 1 H NMR spectroscopy, resulting in the unambiguous identification of etonitazepyne.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom